AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 5787671
Drug: Propranolol, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 20 mg
Trial: 29467598
Drug: Spirulina extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirulina extract (1500 mg for 6 weeks)
Trial: 26595965
Drug: Intravenous laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous laser irradiation in addition to traditional medicamental therapy (Group 2)
Trial: 26595965
Drug: Laser skin
RxNorm normalized name: NIACINAMIDE 0.6 mg in 120 mL TOPICAL LIQUID [Miracle Laser Skin Mist]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser skin treatment (Group 3)
Trial: 26595965
Drug: Traditional medicamental
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional medicamental therapy alone (Control Group 1)
Trial: 17070147
Drug: Aggressive LDL-C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive LDL-C reduction (goal <70 mg/dL)
Trial: 17070147
Drug: Standard LDL-C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard LDL-C reduction (goal <100 mg/dL)
Trial: 13677262
Drug: Combined immunosuppressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined immunosuppressive treatment (antithymocyte globulin, methylprednisolone, and cyclosporine)
Trial: 10021716
Drug: Porcine surfactant
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Porcine surfactant prophylaxis (200 mg/kg endotracheally)
Trial: 3691610
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg trimetazidine (single dose)
Trial: 3691610
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg trimetazidine (chronic administration, three times a day)
Trial: 27468128
Drug: High-fructose diet
RxNorm normalized name: High Fructose Corn Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fructose diet (HFrD) (+3.5 g fructose/kg fat-free mass per day) for 7 days
Trial: 24296342
Drug: Facial exercises
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Facial exercises (daily training for 7 weeks)
Trial: 19004053
Drug: Etanercept (TNF-alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (TNF-alpha antagonist)
Trial: 16648318
Drug: Olanzapine (5‐15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (5‐15 mg/day)
Trial: 12511713
Drug: HDM allergen
RxNorm normalized name: American house dust mite allergenic extract 6 SQ-HDM / European house dust mite allergenic extract 6 SQ-HDM [Odactra]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDM allergen inhalation
Trial: 10368793
Drug: Nasal salmon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal salmon calcitonin (200 IU daily for 2 months, followed by a 2-month pause, repeated for 3 cycles) and 500 mg calcium daily
Trial: 2053087
Drug: Tenoxicam administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam administered at 8 am or 12 pm
Trial: 2053087
Drug: Tenoxicam administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam administered at midday
Trial: 6754331
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g palatinite
Trial: 31071535
Drug: Intramuscular hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular hypertonic saline injection to the vastus medialis
Trial: 31071535
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline injection (sham)
Trial: 22087795
Drug: Brown seaweed
RxNorm normalized name: seaweed extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brown seaweed (Ascophyllum nodosum and Fucus vesiculosus) 500 mg
Trial: 19063686
Drug: PTH(1-34) treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTH(1-34) treatment for 1 year
Trial: 19063686
Drug: PTH(1-34) treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTH(1-34) treatment
Trial: 10833696
Drug: Telephone therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone therapy (10 sessions of 30 minutes each)
Trial: 22163281
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplementation (100, 400, 4000 µg per day) for 6 months
Trial: 19459233
Drug: Higher support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher support (phone coaching plus monthly exercise support group)
Trial: 15353377
Drug: Routine individual
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine individual therapy
Trial: 10665618
Drug: Physostigmine (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (24 mg/d and 30 mg/d)
Trial: 3093918
Drug: Transfer factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfer factor therapy
Trial: 30486630
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy with Inj. Cisplatin 100 mg/m2 for three-weekly and EBRT with 60 Co/LINAC and photon radiation of 70 Gy in 35 fractions for 7 weeks.
Trial: 30486630
Drug: Chemo boost
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemo boost with Inj. Cisplatin 6 mg/m2 on last 15 fractions of treatment and EBRT with 60 Co/LINAC photon radiation of 70 Gy in 35 fractions for 7 weeks.
Trial: 23768683
Drug: Sertraline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline treatment for 12 weeks
Trial: 22169050
Drug: Acetaminophen (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (300 mg) with codeine (30 mg)
Trial: 17065897
Drug: Parecoxib (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parecoxib (40 mg) administered preventively with electrical stimulation
Trial: 17065897
Drug: Parecoxib (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parecoxib (40 mg) administered in parallel to remifentanil infusion
Trial: 11134918
Drug: Counselling (CBT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counselling (CBT or psychodynamic approach) in addition to usual GP treatment
Trial: 11134918
Drug: Usual GP
RxNorm normalized name: carbetapentane citrate / guaifenesin Oral Solution [Pulmari-GP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual GP treatment (Control)
Trial: 9362434
Drug: Pamidronate 90
RxNorm normalized name: pamidronate 90 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate 90 mg as a 2-hour infusion monthly for 2 years
Trial: 1397827
Drug: Monthly journal
RxNorm normalized name: Journavx
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly journal club sessions with two didactic sessions before the club started.
Trial: 4029557
Drug: Gastric distention
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric distention (0, 250, 500, or 750 ml of air for 15 min)
Trial: 30400122
Drug: Meditation (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meditation (45 minutes daily for 6 weeks)
Trial: 20156072
Drug: Low-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat diet plus weight-reducing drugs when necessary
Trial: 17934150
Drug: Prandial premixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prandial premixed therapy (PPT) - lispro mix 50/50 (50% insulin lispro protamine suspension and 50% lispro); n = 187
Trial: 17934150
Drug: Basal/bolus therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal/bolus therapy (BBT) - glargine at bedtime plus mealtime lispro; n = 187
Trial: 6890839
Drug: Standard preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard preparation (40 mg isosorbide dinitrate as retard formulation)
Trial: 28828764
Drug: Topical insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical insulin 0.5 units per drop 4 times per day (QID)
Trial: 28828764
Drug: Topical insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical insulin 1 unit per drop 4 times per day (QID)
Trial: 28828764
Drug: Topical insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical insulin 2 units per drop 4 times per day (QID)
Trial: 26998724
Drug: Chloroquine (CQ)
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine (CQ) 150 mg daily for 8 weeks
Trial: 23787192
Drug: En-masse retraction
RxNorm normalized name: Salazopyrin EN
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: En-masse retraction with mini-implants
Trial: 11981084
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 15 mg/day orally
Trial: 11981084
Drug: Methylcobalamin 500
RxNorm normalized name: methylcobalamin 500 mcg oral lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylcobalamin 500 mg intravenously after each HD, in addition to folic acid
Trial: 11981084
Drug: Vitamin B(6)
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B(6) 60 mg/day orally, in addition to folic acid and methylcobalamin
Trial: 8575497
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg finasteride for 1 year, then 5 mg finasteride for 4 years
Trial: 8575497
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg finasteride for the entire 5 years
Trial: 28107680
Drug: Buprenorphine Treatment
RxNorm normalized name: Buprenorphine
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine Treatment
Trial: 25646328
Drug: PNPLA3 G-allele
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PNPLA3 G-allele carriers
Trial: 19478295
Drug: 6-month naltrexone
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month naltrexone implant
Trial: 17092597
Drug: Unmodified human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unmodified human insulin
Trial: 17092597
Drug: Insulin aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin aspart and unmodified human insulin
Trial: 3126306
Drug: Praziquantel 20-40
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel 20-40 mg kg‐1
Trial: 3126306
Drug: Praziquantel 30-40
RxNorm normalized name: praziquantel 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel 30-40 mg kg‐1
Trial: 3126306
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of praziquantel
Trial: 30412630
Drug: Control (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (not receiving low molecular weight heparin)
Trial: 20536800
Drug: Heat therapy
RxNorm normalized name: CVS Neck Arm & Leg Heat Therapy Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat therapy (n = 31)
Trial: 20536800
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy (n = 29)
Trial: 15536472
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg soybean‐derived pinitol, twice daily for 13 weeks
Trial: 11531789
Drug: Ointment (O)
RxNorm normalized name: Nasal Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment (O)
Trial: 11531789
Drug: Cream (C)
RxNorm normalized name: Oral Cream
DrugBank: Coffea arabica seed, roasted (DB15603)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream (C)
Trial: 11531789
Drug: Solution (S)
RxNorm normalized name: Irrigation Solution
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Solution (S)
Trial: 11531789
Drug: Low-viscosity cream
RxNorm normalized name: polyethylene terephthalate (intrinsic viscosity 0.40-0.70)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-viscosity cream (LVC)
Trial: 9257795
Drug: rhuMAb‐E25 (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhuMAb‐E25 (0.15 mg/kg subcutaneously, 0.15 mg/kg intravenously, or 0.5 mg/kg intravenously)
Trial: 9257795
Drug: Placebo (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (subcutaneous and intravenous)
Trial: 8501148
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist plus estrogen-progestin add-back regimen
Trial: 8501148
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist plus progestin add-back regimen
Trial: 3327939
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment with protein-free artificial surfactant (ALEC)
Trial: 31994022
Drug: ACT‐709478 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT‐709478 30 mg once daily for 12 days
Trial: 31994022
Drug: ACT‐709478 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT‐709478 10 mg once daily for 12 days
Trial: 31994022
Drug: ACT‐709478 10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT‐709478 10, 30, and 60 mg for 7 days each, then 100 mg once daily for 8 days
Trial: 31994022
Drug: ACT‐709478 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT‐709478 60 mg and 100 mg with midazolam
Trial: 30574771
Drug: Combined sea
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined sea salt-based oral rinse with xylitol
Trial: 23881846
Drug: Warfarin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin with major hemorrhage included
Trial: 23881846
Drug: Aspirin with
RxNorm normalized name: Bayer Aspirin with Calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin with major hemorrhage included
Trial: 20797382
Drug: Desvenlafaxine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine (100 or 200 mg/d)
Trial: 18592146
Drug: Corticosteroids (methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (methylprednisolone 40 mg/day)
Trial: 9145453
Drug: N-acetylcysteine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (600 mg/day)
Trial: 18592146
Drug: Basal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal treatment (regular ipratropium bromide and beta‐2 agonist as needed) + placebo CS + placebo NAC
Trial: 18592146
Drug: Basal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal treatment + placebo CS + N-acetylcysteine (600 mg/day)
Trial: 14584228
Drug: Medication review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication review and discharge counselling (Intervention group)
Trial: 10922430
Drug: Front-loaded alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Front-loaded alteplase (up to 100 mg)
Trial: 8757514
Drug: 1 year
RxNorm normalized name: COVID vacc 2024-2025 (5-11 years) (Pfizer)/PF 10 mcg/0.3 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 year of outpatient maintenance treatment
Trial: 30902918
Drug: Anlotinib (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anlotinib (12 mg once daily, 2 weeks on/1 week off)
Trial: 30902918
Drug: Sunitinib (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib (50 mg once daily, 4 weeks on/2 weeks off)
Trial: 18448745
Drug: CDB-2914 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDB-2914 10 mg daily (T1)
Trial: 18448745
Drug: CDB-2914 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDB-2914 20 mg daily (T2)
Trial: 12559539
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (0.03 U/kg per day)
Trial: 9349571
Drug: Levothyroxine (LT4)
RxNorm normalized name: LT4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levothyroxine (LT4) 200 microg daily for 12 months
Trial: 2878812
Drug: Diphenhydramine (DPH)
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (DPH) 50 mg b.d.
Trial: 2878812
Drug: Temelastine (SKF)
RxNorm normalized name: SKF-96365 free base
DrugBank: SKF-96365 free base (DB17054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temelastine (SKF) 100 mg b.d.
Trial: 26964731
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 μg sc daily
Trial: 22437412
Drug: Non-renin-angiotensin-aldosterone system
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-renin-angiotensin-aldosterone system (non-RAASi)-based therapy
Trial: 17302259
Drug: Lamivudine therapy
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine therapy for 6-12 months
Trial: 8888166
Drug: Dry mopping
RxNorm normalized name: 8-MOP
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dry mopping with topical and systemic antibiotics and topical steroids
Trial: 1410148
Drug: Abrupt discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrupt discontinuation of 6 nights of 0.50 mg triazolam
Trial: 1410148
Drug: Tapered discontinuation
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapered discontinuation (3 nights of 0.50 mg, 2 nights of 0.25 mg, and 1 night of 0.125 mg triazolam)
Trial: 23390923
Drug: Intravenous t-PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous t-PA alone
Trial: 19000581
Drug: recombinant birch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant birch pollen allergen vaccine (rBet v 1)
Trial: 12875064
Drug: Kidney-tonifying prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kidney-tonifying prescription and routine western drugs
Trial: 11794070
Drug: WHO formula
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL LIQUID [Hand Sanitizer WHO Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHO formula vaccines
Trial: 11794070
Drug: FDA formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDA formula vaccines
Trial: 9124058
Drug: Oral challenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral challenge test with boiled egg and freeze-dried egg white
Trial: 9124058
Drug: 20 min
RxNorm normalized name: wheat germ oil 20 minim ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 min patch test with raw egg white
Trial: 9124058
Drug: 20 min
RxNorm normalized name: wheat germ oil 20 minim ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 min patch test with freeze-dried egg white
Trial: 9124058
Drug: IgE antibody
RxNorm normalized name: IG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgE antibody titers to egg white components
Trial: 9124058
Drug: IgE antibody
RxNorm normalized name: IG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgE antibody titers for ovomucoid fragments digested by pepsin, chymotrypsin, and trypsin
Trial: 27873388
Drug: Sildenafil 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 60 mg three times a day
Trial: 25421976
Drug: Dietary nitrate
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary nitrate (250 mL daily, as beetroot juice)
Trial: 25421976
Drug: Placebo (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (250 mL daily, as nitrate-free beetroot juice)
Trial: 24350416
Drug: Benzydamine hydrochloride
RxNorm normalized name: benzydamine hydrochloride
DrugBank: Benzydamine (DB09084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzydamine hydrochloride (3 ml, 4.5 mg) dripped on ETT cuff
Trial: 19038563
Drug: Laronidase 0.58
RxNorm normalized name: laronidase 0.58 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laronidase 0.58 mg/kg once-weekly intravenous infusion
Trial: 19038563
Drug: Laronidase 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laronidase 1.2 mg/kg every 2 weeks
Trial: 19038563
Drug: Laronidase 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laronidase 1.2 mg/kg every week
Trial: 19038563
Drug: Laronidase 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laronidase 1.8 mg/kg every 2 weeks
Trial: 19038563
Drug: All dose
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All dose regimens
Trial: 11944733
Drug: Orthosiphon grandiflorus
RxNorm normalized name: Orthosiphon
DrugBank: Orthosiphon aristatus leaf (DB15838)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthosiphon grandiflorus (OG) tea, 2 cups daily (2.5 g dry wt per tea bag)
Trial: 11944733
Drug: Sodium potassium
RxNorm normalized name: SODIUM POTASSIUM ALUMINUM SILICATE
DrugBank: Sodium nitrate (DB15952)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium potassium citrate (SPC), 5-10 g in solution divided into three times a day